Skip to main navigation
logo
  • Overview
  • News & Events
    • Press Releases
    • Calendar of Events
    • Presentations
  • Financial Info
    • SEC Filings
    • Supplemental Financial Information
  • Corporate Governance
    • Documents & Charters
    • Leadership
    • Board of Directors
    • Committee Composition
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Investor Resources
    • FAQ
    • Information Requests
    • IR Contact

Lantheus Holdings, Inc. Reports Third Quarter 2020 Financial Results

  • Read more about Lantheus Holdings, Inc. Reports Third Quarter 2020 Financial Results

Lantheus Holdings to Present at November 2020 Investor Conferences

  • Read more about Lantheus Holdings to Present at November 2020 Investor Conferences

Lantheus Enters into Strategic Collaboration with Insightec for Use of Microbubbles in Combination with MR-Guided Focused Ultrasound for Treatment of Glioblastoma and Neurodegenerative Conditions

  • Read more about Lantheus Enters into Strategic Collaboration with Insightec for Use of Microbubbles in Combination with MR-Guided Focused Ultrasound for Treatment of Glioblastoma and Neurodegenerative Conditions

Lantheus Holdings to Host Third Quarter 2020 Earnings Conference Call and Webcast on November 5, 2020 at 8:00 a.m. Eastern Time

  • Read more about Lantheus Holdings to Host Third Quarter 2020 Earnings Conference Call and Webcast on November 5, 2020 at 8:00 a.m. Eastern Time

Lantheus Holdings Announces Presentations at the 33rd Annual European Association of Nuclear Medicine (EANM) Virtual Congress

  • Read more about Lantheus Holdings Announces Presentations at the 33rd Annual European Association of Nuclear Medicine (EANM) Virtual Congress

Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyL™ (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agent

  • Read more about Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyL™ (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agent

Lantheus Holdings to Present at the Wells Fargo 2020 Virtual Healthcare Conference

  • Read more about Lantheus Holdings to Present at the Wells Fargo 2020 Virtual Healthcare Conference

Lantheus Holdings, Inc. Announces FDA Approval of VIALMIX® RFID Device for DEFINITY®

  • Read more about Lantheus Holdings, Inc. Announces FDA Approval of VIALMIX® RFID Device for DEFINITY®

Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results

  • Read more about Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results

Lantheus Holdings to Host Second Quarter 2020 Earnings Conference Call on July 30, 2020 at 8:00 a.m. Eastern Time

  • Read more about Lantheus Holdings to Host Second Quarter 2020 Earnings Conference Call on July 30, 2020 at 8:00 a.m. Eastern Time

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Current page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Site - Shareholder Services

Print Page
RSS Feeds
Email Alerts
  • Copyright © 2025 Lantheus Holdings, Inc. All rights reserved.